Recombinant multi-species Aconitase 1/ACO1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine Aconitase 1/ACO1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The protein encoded by this gene is a bifunctional, cytosolic protein that functions as an essential enzyme in the TCA cycle and interacts with mRNA to control the levels of iron inside cells. When cellular iron levels are high, this protein binds to a 4Fe-4S cluster and functions as an aconitase. Aconitases are iron-sulfur proteins that function to catalyze the conversion of citrate to isocitrate. When cellular iron levels are low, the protein binds to iron-responsive elements (IREs), which are stem-loop structures found in the 5' UTR of ferritin mRNA, and in the 3' UTR of transferrin receptor mRNA. When the protein binds to IRE, it results in repression of translation of ferritin mRNA, and inhibition of degradation of the otherwise rapidly degraded transferrin receptor mRNA. The encoded protein has been identified as a moonlighting protein based on its ability to perform mechanistically distinct functions. Alternative splicing results in multiple transcript variants [provided by RefSeq, Jan 2014]
The Alternative Names of target: ACO1,ACONS,AH,Aco-1,Aco1,Acon1,Aconitase,Aconitase 1,Citrate hydro-lyase,Cytoplasmic aconitate hydratase,Ferritin repressor protein,HEL60,IREB1,IREBP,IREBP1,IRP1,Irebp,Iron regulatory protein 1 (IRP1),Iron-responsive element-binding protein 1 (IRE-BP 1),Irp1
Go
to Aconitase 1/ACO1 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-IP9105-Ag-1/ GM-Tg-hg-IP9105-Ag-2 | Human Aconitase 1/ACO1 protein | Human |
GM-Tg-rg-IP9105-Ag-1/ GM-Tg-rg-IP9105-Ag-2 | Rat Aconitase 1/ACO1 protein | Rat |
GM-Tg-mg-IP9105-Ag-1/ GM-Tg-mg-IP9105-Ag-2 | Mouse Aconitase 1/ACO1 protein | Mouse |
GM-Tg-cynog-IP9105-Ag-1/ GM-Tg-cynog-IP9105-Ag-2 | Cynomolgus/Rhesus macaque Aconitase 1/ACO1 protein | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-IP9105-Ag-1/ GM-Tg-felg-IP9105-Ag-2 | Feline Aconitase 1/ACO1 protein | Feline |
GM-Tg-cang-IP9105-Ag-1/ GM-Tg-cang-IP9105-Ag-2 | Canine Aconitase 1/ACO1 protein | Canine |
GM-Tg-bovg-IP9105-Ag-1/ GM-Tg-bovg-IP9105-Ag-2 | Bovine Aconitase 1/ACO1 protein | Bovine |
GM-Tg-equg-IP9105-Ag-1/ GM-Tg-equg-IP9105-Ag-2 | Equine Aconitase 1/ACO1 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. |
GM-Tg-hg-IP9105-Ag-1/ GM-Tg-hg-IP9105-Ag-2;
GM-Tg-rg-IP9105-Ag-1/ GM-Tg-rg-IP9105-Ag-2;
GM-Tg-mg-IP9105-Ag-1/ GM-Tg-mg-IP9105-Ag-2; GM-Tg-cynog-IP9105-Ag-1/ GM-Tg-cynog-IP9105-Ag-2; GM-Tg-felg-IP9105-Ag-1/ GM-Tg-felg-IP9105-Ag-2; GM-Tg-cang-IP9105-Ag-1/ GM-Tg-cang-IP9105-Ag-2; GM-Tg-bovg-IP9105-Ag-1/ GM-Tg-bovg-IP9105-Ag-2; GM-Tg-equg-IP9105-Ag-1/ GM-Tg-equg-IP9105-Ag-2 |
Products Name | Aconitase 1/ACO1 protein |
Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
Target Name | Aconitase 1/ACO1 |
Protein Sub-location | Introcelluar Protein |
Isotypes | Recombinant protein |
Expression platform | Mammalian cell |
Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
Tag | His |
Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine Aconitase 1/ACO1 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab
GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.